Bruker's Mass-Spec Sales Grow in Double Digits in Q2; Total Revenue Declines 18.9 Percent

According to Frank Laukien, president and CEO of the company, "for our high performance mass spectrometry solutions, we continue to see healthy revenue and order growth year over year."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.